Cargando…
Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR
BACKGROUND: On-target resistance mechanisms found in one-third of patients receiving anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) are secondary ALK mutations in ALK-rearranged non-small cell lung cancer (NSCLC). There are large variations in the resistant mutations, unlike the...
Autores principales: | Yoshida, Ryohei, Sasaki, Takaaki, Umekage, Yasuhiro, Tanno, Sachie, Ono, Yusuke, Ogata, Munehiko, Chiba, Shinichi, Mizukami, Yusuke, Ohsaki, Yoshinobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245722/ https://www.ncbi.nlm.nih.gov/pubmed/30453899 http://dx.doi.org/10.1186/s12885-018-5031-0 |
Ejemplares similares
-
Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in ALK-Rearranged Non-small Cell Lung Cancers
por: Hirai, Noriko, et al.
Publicado: (2020) -
Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR
por: Ariyasu, Ryo, et al.
Publicado: (2021) -
Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancer
por: Hirai, Noriko, et al.
Publicado: (2021) -
Two Cases of SMARCA4-Deficient Non-small Cell Lung Cancer (NSCLC) with Improved Performance Status (PS) after Treatment with Immune Checkpoint Inhibitors (ICIs)
por: Koizumi, Akiko, et al.
Publicado: (2023) -
An improved digital polymerase chain reaction protocol to capture low‐copy KRAS mutations in plasma cell‐free DNA by resolving ‘subsampling’ issues
por: Ono, Yusuke, et al.
Publicado: (2017)